trial · primary record
Lemborexant 5 mg
Brain Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 112 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Total Sleep Time (TST) on the Night Before Surgery |
| Registry ID | NCT07903051 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:30.178Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07903051
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lemborexant 5 Mg · compound